Improving Patient Outcomes Without Breaking the Bank
Ed Finkel
About three-quarters of all drugs approved by the U.S. Food and Drug Administration in 2023 were considered specialty drugs, and seven of the top 10 most expensive drugs have been approved in the past two years, according to statistics compiled by pharmacy finance authority IPD Analytics.
Read More